Pernix Therapeutics (NASDAQ: PTX) today announced that the central patent for Zohydro ER® with BeadTek™, U.S. Patent Number 9,132,096, has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE